These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

885 related articles for article (PubMed ID: 32391806)

  • 1. Immune responses to stroke: mechanisms, modulation, and therapeutic potential.
    Iadecola C; Buckwalter MS; Anrather J
    J Clin Invest; 2020 Jun; 130(6):2777-2788. PubMed ID: 32391806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Targets for Modulation of Immune Response and Inflammation in Stroke.
    Thapa K; Shivam K; Khan H; Kaur A; Dua K; Singh S; Singh TG
    Neurochem Res; 2023 Jun; 48(6):1663-1690. PubMed ID: 36763312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Yin and Yang of innate immunity in stroke.
    Xu X; Jiang Y
    Biomed Res Int; 2014; 2014():807978. PubMed ID: 24877133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunology of stroke: from mechanisms to translation.
    Iadecola C; Anrather J
    Nat Med; 2011 Jul; 17(7):796-808. PubMed ID: 21738161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive Immunity Regulation and Cerebral Ischemia.
    Qin X; Akter F; Qin L; Cheng J; Guo M; Yao S; Jian Z; Liu R; Wu S
    Front Immunol; 2020; 11():689. PubMed ID: 32477327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Involvement and Therapy Target of Immune Cells After Ischemic Stroke.
    Jian Z; Liu R; Zhu X; Smerin D; Zhong Y; Gu L; Fang W; Xiong X
    Front Immunol; 2019; 10():2167. PubMed ID: 31572378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TARGETING NEUROINFLAMMATION FOR TREATMENT OF ISCHEMIC STROKE.
    Kokaia Z
    Georgian Med News; 2015 Jun; (243):84-7. PubMed ID: 26087739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses in stroke: how the immune system contributes to damage and healing after stroke and how this knowledge could be translated to better cures?
    Rayasam A; Hsu M; Kijak JA; Kissel L; Hernandez G; Sandor M; Fabry Z
    Immunology; 2018 Jul; 154(3):363-376. PubMed ID: 29494762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia.
    Brait VH; Arumugam TV; Drummond GR; Sobey CG
    J Cereb Blood Flow Metab; 2012 Apr; 32(4):598-611. PubMed ID: 22293986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
    Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
    Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation.
    Tsuyama J; Nakamura A; Ooboshi H; Yoshimura A; Shichita T
    Semin Immunopathol; 2018 Nov; 40(6):523-538. PubMed ID: 30206661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous Protection from Ischemic Brain Injury by Preconditioned Monocytes.
    Garcia-Bonilla L; Brea D; Benakis C; Lane DA; Murphy M; Moore J; Racchumi G; Jiang X; Iadecola C; Anrather J
    J Neurosci; 2018 Jul; 38(30):6722-6736. PubMed ID: 29946039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory responses in brain ischemia.
    Kawabori M; Yenari MA
    Curr Med Chem; 2015; 22(10):1258-77. PubMed ID: 25666795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Cellular Therapies for Acute Ischemic Stroke.
    Mays RW; Savitz SI
    Stroke; 2018 May; 49(5):1058-1065. PubMed ID: 29669867
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenic mechanisms following ischemic stroke.
    Khoshnam SE; Winlow W; Farzaneh M; Farbood Y; Moghaddam HF
    Neurol Sci; 2017 Jul; 38(7):1167-1186. PubMed ID: 28417216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term T cell responses in the brain after an ischemic stroke.
    Selvaraj UM; Stowe AM
    Discov Med; 2017 Dec; 24(134):323-333. PubMed ID: 29373810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Local and Peripheral Immune Responses to Stroke: Implications for Therapeutic Development.
    Zera KA; Buckwalter MS
    Neurotherapeutics; 2020 Apr; 17(2):414-435. PubMed ID: 32193840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research progress on immune-related therapeutic targets of brain injury caused by cerebral ischemia.
    He Y; Jin W; Wan H; Zhang L; Yu L
    Cytokine; 2024 Aug; 180():156651. PubMed ID: 38761715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-stroke immunodeficiency: effects of sensitization and tolerization to brain antigens.
    Esmaeili A; Dadkhahfar S; Fadakar K; Rezaei N
    Int Rev Immunol; 2012 Oct; 31(5):396-409. PubMed ID: 23083348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Sex Differences in the Immune-Inflammatory Responses to Neonatal Ischemic Stroke.
    Villapol S; Faivre V; Joshi P; Moretti R; Besson VC; Charriaut-Marlangue C
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.